A bankruptcy judge Friday paved the way for Dendreon to auction its flagship, Provenge, to the highest bidder, a day after Valeant Pharmaceuticals set a $296 million floor price for the prostate cancer drug.
WSJ.com: US Business, Wall Street Journal: Business
Fri, 01/30/2015 - 12:32pm
A bankruptcy judge Friday paved the way for Dendreon to auction its flagship, Provenge, to the highest bidder, a day after Valeant Pharmaceuticals set a $296 million floor price for the prostate cancer drug.